4-Bromo-5-cyclopropyl-2-methyl-2H-pyrazol-3-ylamine, 1g

Boc-Phg-OH, >98%, 500g

(1S,3aR,4S,7aS)-1-((S)-1-(3-hydroxy-3-methylbutoxy)ethyl)-7a-methyloctahydro-1H-inden-4-ol, 97%, 1g

3-(Bromomethyl)-2-cyclopropyl-4-(4-fluorophenyl)quinoline, 95.0%, 5g

(2S,4R)-1-((S)-14-amino-2-(tert-butyl)-4-oxo-6,9,12-trioxa-3-azatetradecan-1-oyl)-4-hydroxy-N-(4-(4-methylthiazol-5-yl)benzyl)pyrrolidine-2-carboxamidehydrochloride, 95%, 2g

N-[3-[[5-Fluoro-2-[[4-(2-methoxyethoxy)phenyl]amino]-4-pyrimidinyl]amino]phenyl]-2-propenamide, 98%, 250mg

(4-BROMO-3-METHYLPHENYL)(4-METHOXY-3-NITROPHENYL)METHANONE, 95.0%, 100mg

Ethoxy Terminated Polydimethylsiloxane, 5-10 cSt, 100g

2-(2-((((9H-FLUOREN-9-YL)METHOXY)CARBONYL)AMINO)-2-METHYLPROPANAMIDO)-2-METHYLPROPANOIC ACID, 95%, 1g

trans-3-Aminocyclobutanecarboxylic acid, 95.0%, 1g

Acotiamide, 98%, 250mg

2-Methylthiazole-4-carboxamide, 95.0%, 10g

9-(4-Nitrophenyl)-9H-carbazole, 97%, 10g